Sponsor Pipeline

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07546500 A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With… Ovarian Cancer Recruiting
Phase 2
NCT05128825 A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous… High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer Recruiting
Phase 1
NCT04516447 A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer Solid Tumor Recruiting
Disease Areas
Ovarian Cancer (2)
Get alerts when K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free